Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician Roopa MehtaDaniel PichelAndrei C. Sposito Guidelines Open access 15 December 2020 Pages: 1 - 20
Diabetic Kidney Disease Benefits from Intensive Low-Protein Diet: Updated Systematic Review and Meta-analysis Qiuling LiFeng WenWenjian Wang Review Open access 04 November 2020 Pages: 21 - 36
African Cuisine-Centered Insulin Therapy: Expert Opinion on the Management of Hyperglycaemia in Adult Patients with Type 2 Diabetes Mellitus Jean Claude MbanyaRoberta LampteySanjay Kalra Review Open access 09 November 2020 Pages: 37 - 54
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same? A Narrative Review of Cardiovascular Outcome Trials David M. WilliamsAsif NawazMarc Evans Review Open access 13 November 2020 Pages: 55 - 70
Diabetes and Bone Fragility Camila Romero-DíazDaniela Duarte-MonteroCarlos O. Mendivil Review Open access 13 November 2020 Pages: 71 - 86
Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications Marc EvansAngharad R. MorganUmesh Dashora Review Open access 14 November 2020 Pages: 87 - 105
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes Sandro GentileGiuseppina GuarinoNefrocenter Network and Nyx Start-up Study Group Review Open access 21 November 2020 Pages: 107 - 119
Inpatient Hyperglycemia Management and COVID-19 Virginia BellidoAntonio Pérez Review Open access 05 December 2020 Pages: 121 - 132
Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel Manoj ChawlaSunil M. JainNirmalya Roy Review Open access 12 December 2020 Pages: 133 - 142
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials Thinzar MinStephen C. Bain Review Open access 15 December 2020 Pages: 143 - 157
Psychometric Analysis Regarding the Barriers to Providing Effective Insulin Treatment in Type 2 Diabetic Patients Eu Jeong KuDong-Hwa LeeTae Keun Oh Original Research Open access 24 October 2020 Pages: 159 - 170
Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus Kyung-Soo KimSangmo HongCheol-Young Park Original Research Open access 24 October 2020 Pages: 171 - 181
Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study Masaya KoshizakaKo IshikawaKoutaro Yokote Original Research Open access 24 October 2020 Pages: 183 - 196
Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira) Luciano ZenariAndrea Da PortoAnnunziata Lapolla Original Research Open access 26 October 2020 Pages: 197 - 209
Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors Jianhua MaBin ZhangYongde Peng Original Research Open access 08 November 2020 Pages: 211 - 222
Screening for Diabetic Retinopathy with Extended Intervals, Safe and Without Compromising Adherence: A Retrospective Cohort Study Ali SharifJohan JendleKarl-Johan Hellgren Original Research Open access 09 November 2020 Pages: 223 - 234
Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France Stéphane RozeJohn J. IsittPierre-Yves Benhamou Original Research Open access 09 November 2020 Pages: 235 - 246
Prevalence of Incretin-Mimetic and Sodium-Glucose-Transporter-2-Inhibitor Therapy in German Hospitalized Type-2 Diabetics Following Myocardial Revascularization: An Observational Study Rainer U. PliquettLinda GolleMatthias Girndt Original Research Open access 16 November 2020 Pages: 247 - 259
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect Dragana NikolicRosaria Vincenza GiglioManfredi Rizzo Original Research Open access 18 November 2020 Pages: 261 - 274
Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China Xiaoning HeYawen ZhangJing Wu Original Research Open access 18 November 2020 Pages: 275 - 288
Missense Variants in PAX4 Are Associated with Early-Onset Diabetes in Chinese Aibo GaoBin GuWeiqiong Gu Original Research Open access 20 November 2020 Pages: 289 - 300
The Treatment Effectiveness Evaluation for Slowing the Progression of Diabetic Nephropathy During Stage 4 Chronic Kidney Disease Tianyu YuShimin JiangWenge Li Original Research Open access 29 November 2020 Pages: 301 - 312
Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model Michael WillisAndreas NilssonIsabelle Newell Original Research Open access 02 December 2020 Pages: 313 - 328
Nutritional Status of Pediatric Patients with Type 1 Diabetes Mellitus from Northeast Poland: A Case-Control Study Monika GrabiaRenata Markiewicz-Żukowska Original Research Open access 08 December 2020 Pages: 329 - 343
Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57) Yasushi IshigakiAlena StrizekHiroshi Maegawa Original Research Open access 09 December 2020 Pages: 345 - 361
Improving HbA1c Control in Type 1 or Type 2 Diabetes Using Flash Glucose Monitoring: A Retrospective Observational Analysis in Two German Centres Ludger RoseGerhard KlausmannAlexander Seibold Original Research Open access 11 December 2020 Pages: 363 - 372
Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis Johan JendleÅsa EricssonBarnaby Hunt Original Research Open access 11 December 2020 Pages: 373 - 388
Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis Dominik LautschAdnan AlsumaliSwapnil Rajpathak Original Research Open access 12 December 2020 Pages: 389 - 418
Personality Traits, Metabolic Control and the Use of Insulin Pump Functions in Adults With Type 1 Diabetes: An Observational Single-Visit Study Agnieszka NiemiecAgata JurućLilianna Majkowska Original Research Open access 15 December 2020 Pages: 419 - 430
A Prospective, Open-Label Short-Term Pilot Study on Modification of the Skin Hydration Status During Treatment With a Sodium-Glucose Cotransporter-2 Inhibitor Yuji TezukaOsamu SekineAtsunori Kashiwagi Brief Report Open access 27 October 2020 Pages: 431 - 440
A Comparison of Validated Methods Used to Assess Impaired Awareness of Hypoglycaemia in Type 1 Diabetes: An Observational Study Kshitiz GhandiBeatrice PieriSufyan Hussain Brief Report Open access 20 November 2020 Pages: 441 - 451
Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan Ryoichi IshibashiYusuke BabaFumitaka Okajima Brief Report Open access 25 November 2020 Pages: 453 - 460